No. | Sex | Age | Lesion location | Pathology | Diagnosis | Adverse events |
---|---|---|---|---|---|---|
1 | F | 71 | #4R, mass | Adenocarcinoma | P | NO |
2 | F | 62 | #4R, mass | Small cell lung cancer | P | NO |
3 | F | 67 | #7, #11R, mass | Granuloma | P | NO |
4 | F | 52 | #7, mass | Granuloma | P | NO |
5 | M | 78 | #4R, #7 | Small cell lung cancer | P | NO |
6 | F | 51 | #7, #11R | Granuloma | P | NO |
7 | M | 65 | #4R, #7, #11R | Adenocarcinoma | P | NO |
8 | F | 44 | mass | Granuloma | P | NO |
9 | M | 57 | mass | Squamous Carcinoma | P | NO |
10 | M | 58 | #7 | Adenocarcinoma | P | NO |
11 | M | 56 | #7, mass | Adenocarcinoma | P | NO |
12 | M | 59 | #7, #11L | Adenocarcinoma | P | NO |
13 | M | 62 | #4R, #7, #4L | Small cell lung cancer | P | NO |
14 | M | 58 | #4R, mass | Small cell lung cancer | P | NO |
15 | M | 75 | #11R | Inflammation | P | NO |
16 | F | 50 | #4R, mass | Granuloma | P | NO |
17 | M | 51 | #4R, mass | Adenocarcinoma | P | NO |
18 | M | 73 | #7, #11R, mass | Inflammation | P | Transient |
19 | M | 56 | #7, mass | Adenocarcinoma | P | NO |
20 | M | 71 | #4R, #7 | Granuloma | P | NO |
21 | F | 49 | #7, #11R | ND | N | NO |
22 | M | 48 | #4R, #7, #11R | ND | N | NO |
23 | M | 72 | mass | Adenocarcinoma | P | NO |
24 | M | 56 | mass | Inflammation | P | NO |
25 | M | 70 | #7 | Granuloma | P | NO |